Form 4: Achieve Life Sciences CEO John Bencich Reports Stock Transactions

CEO John Bencich reports acquisition of 25,000 shares of Achieve Life Sciences common stock upon settlement of performance restricted stock units and disposition of 6,088 shares for tax liability.

Summary

• On April 19, 2024, John Bencich, CEO of Achieve Life Sciences, acquired 25,000 shares of common stock upon the settlement of performance restricted stock units (PRSUs).
• The CEO also disposed of 6,088 shares of common stock to satisfy tax liabilities related to the PRSU settlement at a price of $4.51.
• Following these transactions, Bencich directly owns 95,636 shares of Achieve Life Sciences common stock.
• The reported transactions involve PRSUs, where each unit represents a contingent right to receive one share of the issuer's common stock at settlement.
• 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone.

Sentiment

Score: 6

Explanation: Neutral sentiment as it reflects routine stock transactions related to executive compensation. The vesting of PRSUs suggests achievement of performance milestones, which is mildly positive.

Positives

• The vesting of PRSUs indicates the achievement of performance-based milestones, which could be seen as a positive sign for the company's performance.

Negatives

• The disposal of shares to cover tax liabilities, while a normal occurrence, could be interpreted as a slight negative if investors believe the CEO might have preferred to hold those shares.

Risks

• There are no specific risks mentioned in this document.
• However, the value of the stock could be affected by the company's future performance and market conditions.

Future Outlook

There is no future outlook provided in this document.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders reporting changes in their beneficial ownership of company stock. It doesn't provide specific insights into the broader industry trends but reflects the compensation structure and equity ownership of the company's CEO.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in the CEO's holdings, but it is unlikely to be significant.

Key Dates